Bicycle Therapeutics (BCYC) Operating Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -733,089.00 |
| Dec 31, 2025 | 50,712.00 |
| Sep 30, 2025 | 240,718.00 |
| Jun 30, 2025 | -226,216.00 |
| Mar 31, 2025 | 112,113.00 |
| Dec 31, 2024 | 56,109.00 |
| Sep 30, 2024 | -188,756.00 |
| Jun 30, 2024 | -19,335.00 |
| Mar 31, 2024 | 71,239.00 |
| Dec 31, 2023 | -6,823.00 |
| Sep 30, 2023 | -57,086.00 |
| Jun 30, 2023 | 47,555.00 |
| Mar 31, 2023 | -47,036.00 |
| Dec 31, 2022 | 59,545.00 |
| Sep 30, 2022 | -65,391.00 |
| Jun 30, 2022 | 38,440.00 |
| Mar 31, 2022 | 41,710.00 |
| Dec 31, 2021 | -79,661.00 |
| Sep 30, 2021 | 63,801.00 |
| Jun 30, 2021 | -8,162.00 |
| Mar 31, 2021 | -44,294.00 |
| Dec 31, 2020 | -16,550.00 |
| Sep 30, 2020 | 52,310.00 |
| Jun 30, 2020 | 23,031.00 |
| Mar 31, 2020 | -94,106.00 |
| Dec 31, 2019 | 157,966.00 |
| Sep 30, 2019 | -114,503.00 |
| Jun 30, 2019 | -47,324.00 |
| Mar 31, 2019 | 66,193.00 |
| Dec 31, 2018 | -31,868.00 |
| Sep 30, 2018 | -9,635.00 |